Yet, another indirect RKIP agonist is anti-CD20 LFB-R603 [201] and Rituximab, an anti-CD20 monoclonal antibody that was found to increase RKIP expression in B-cell non-Hodgkin lymphoma (NHL) cells [155,202]. Here, PEBP1 is linked to B-cell non-Hodgkin lymphoma.